TNBC.Envita incorporates advanced Antibody-Drug Conjugates (ADCs) as part of modern cancer treatment strategies. These therapies deliver targeted chemotherapy directly to cancer cells. Combined with molecular profiling for cancer and personalized cancer medicine, ADCs represent a powerful step forward in precision oncology and TNBC care. https://tnbc.envita.com/